T

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Watchlist Manager
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Watchlist
Price: 3 202.65 INR 2.07% Market Closed
Market Cap: 1.1T INR
Have any thoughts about
Torrent Pharmaceuticals Ltd?
Write Note

Torrent Pharmaceuticals Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torrent Pharmaceuticals Ltd
Cost of Revenue Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
LUPIN
M
MANKIND

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cost of Revenue
-â‚ą27.3B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Cipla Ltd
NSE:CIPLA
Cost of Revenue
-â‚ą87.8B
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cost of Revenue
-â‚ą105.8B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-10%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Cost of Revenue
-â‚ą61.4B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Lupin Ltd
NSE:LUPIN
Cost of Revenue
-â‚ą67.4B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-5%
M
Mankind Pharma Ltd
NSE:MANKIND
Cost of Revenue
-â‚ą34B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Torrent Pharmaceuticals Ltd's Cost of Revenue?
Cost of Revenue
-27.3B INR

Based on the financial report for Jun 30, 2024, Torrent Pharmaceuticals Ltd's Cost of Revenue amounts to -27.3B INR.

What is Torrent Pharmaceuticals Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-8%

Over the last year, the Cost of Revenue growth was 0%. The average annual Cost of Revenue growth rates for Torrent Pharmaceuticals Ltd have been -7% over the past three years , -4% over the past five years , and -8% over the past ten years .

Back to Top